Finnegan is pleased to release
The Chemical and Pharmaceutical Innovation Report 2013. The
Report 2013 is a complimentary eBook for patent practitioners,
entrepreneurs, business executives, venture capitalists, and
inventors that benchmarks the patent activities of the U.S.
chemical and pharmaceutical industries from 2006 to 2012.
Whether your company is emerging or well established, intellectual
property—particularly patents—plays an important role
in its value. Today's patents are not just for corporate
display cases—they are strategic instruments crucial for
business innovation and growth. In the competitive chemical and
pharmaceutical industries, patents protect products that have years
of research and development invested in them.
The Report 2013 examines the chemical and pharmaceutical
industries' patent activities by reviewing:
- Patenting and Application Publication Trends
- District Court Litigation Trends
- Appellate Litigation Trends
- The America Invents Act
- Chemical and Pharmaceutical Federal Circuit Cases from 2006 to 2012
Download a complimentary copy of The Report 2013 eBook here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
